tiprankstipranks
Trending News
More News >
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
US Market
Advertisement

Legend Biotech (LEGN) Income Statement

Compare
576 Followers

Legend Biotech Income Statement

Last quarter (Q3 2025), Legend Biotech's total revenue was $272.33M, an increase of 69.99% from the same quarter last year. In Q3, Legend Biotech's net income was $-39.69M. See Legend Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 627.24M$ 285.14M$ 117.00M$ 68.83M$ 75.00M
Gross Profit
$ 392.66M$ 140.93M$ 51.64M$ 68.83M$ 75.00M
Operating Expenses
$ 695.90M$ 580.41M$ 507.26M$ 461.11M$ 75.00M
Depreciation and Amortization
$ 23.36M$ 20.45M$ 18.39M$ 13.92M$ 9.93M
EBITDA
$ -113.16M$ -477.87M$ -416.54M$ -392.38M$ -298.16M
Operating Income
$ -303.24M$ -439.49M$ -455.62M$ -392.29M$ 0.00
Other Income/Expenses
$ 145.11M$ -80.63M$ 9.90M$ -14.91M$ -308.29M
Pretax Income
$ -158.13M$ -520.12M$ -445.72M$ -407.20M$ -308.29M
Net Income
$ -177.03M$ -518.25M$ -446.35M$ -403.58M$ -266.37M
Per Share Metrics
Basic EPS
$ -1.94$ -5.88$ -5.62$ -5.48$ -5.14
Diluted EPS
$ -1.94$ -5.88$ -5.62$ -5.48$ -5.14
Weighted Average Shares Outstanding
91.43M 88.04M 79.52M 70.43M 59.08M
Weighted Average Shares Outstanding (Diluted)
91.43M 88.04M 79.52M 70.43M 59.08M
Currency in USD

Legend Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis